References
- Chen C, Yang Z, Li Z Li L (2012). Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis. Int J Gynecol Cancer, 22, 908-21. https://doi.org/10.1097/IGC.0b013e318256e5e4
- Cuzick J, Arbyn M, Sankaranarayanan R, et al (2008). Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine, 10, 29-41.
- Esajas MD, Duk JM, de Bruijn HW, et al (2001). Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol, 19, 3960-6. https://doi.org/10.1200/JCO.2001.19.19.3960
- Forni F, Ferrandina G, Deodato F, et al (2007). Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness. Int J Radiat Oncol Biol Phys, 69, 1145-9. https://doi.org/10.1016/j.ijrobp.2007.04.055
- Gadducci A, Cosio S, Carpi A, Nicolini A, Genazzani AR (2004). Serum tumor markers in the management of ovarian, endometrial and cervical cancer. Biomed Pharmacother, 58, 24-38. https://doi.org/10.1016/j.biopha.2003.11.003
- Hong JH, Tsai CS, Chang JT, et al (1998). The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. Int J Radiat Oncol Biol Phys, 41, 823-30. https://doi.org/10.1016/S0360-3016(98)00147-3
- Indarti J, Aziz MF, Suryawati B, Fernando D (2013). Scoring system and management algorithm assessing the role of survivin expression in predicting progressivity of HPV infections in precancerous cervical lesions. Asian Pac J Cancer Prev, 14, 1643-7. https://doi.org/10.7314/APJCP.2013.14.3.1643
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jeong BK, Choi DH, Huh SJ, et al (2011). The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix. Radiat Oncol J, 29, 191-8. https://doi.org/10.3857/roj.2011.29.3.191
- Jesdapatarakul S, Tangjitgamol S, Nguansangiam S, Manusirivithaya S (2011). Liqui-Prep(R) versus conventional Papanicolaou smear to detect cervical cells abnormality by split-sample technique: a randomized double-blind controlled trial. Diagn Cytopathol, 39, 22-7. https://doi.org/10.1002/dc.21320
- Juang CM, Wang PH, Yen MS, et al (2000). Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 76, 103-6. https://doi.org/10.1006/gyno.1999.5665
- Kato H, Torigoe T (1977). Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer, 40, 1621-8. https://doi.org/10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I
- Mathew A, George PS (2009). Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide. Asian Pac J Cancer Prev, 10, 645-50.
- Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
- Parkin DM, Almonte M, Bruni L, et al (2008). Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region. Vaccine, 11, 1-15.
- Porika M, Vemunoori AK, Tippani R, et al (2010). Squamous cell carcinoma antigen and cancer antigen 125 in Southern Indian cervical cancer patients. Asian Pac J Cancer Prev, 11, 1745-7.
- Reesink-Peters N, van der Velden J, Ten Hoor KA, et al (2005). Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J Clin Oncol, 23, 1455-62. https://doi.org/10.1200/JCO.2005.02.123
- Takeshima N, Hirai Y, Katase K, et al (1998). The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol, 68, 263-6. https://doi.org/10.1006/gyno.1998.4939
- Tendler A, Kaufman HL, Kadish AS (2000). Increased carcinoembryonic antigen expression in cervical intraepithelial neoplasia grade 3 and in cervical squamous cell carcinoma. Hum Pathol, 31, 1357-62. https://doi.org/10.1016/S0046-8177(00)80004-0
- Volgger B, Aspisirengil C, Genser-Krimbacher E, et al (2008). Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix. Cancer Lett, 262, 183-9. https://doi.org/10.1016/j.canlet.2007.12.005
- Wallace D, Hunter J, Papenfuss M, et al (2007). Pap smear screening among women >/=40 years residing at the United States-Mexico border. Health Care Women Int, 28, 799-816. https://doi.org/10.1080/07399330701563111
Cited by
- The assessment of the prognostic value of tumor markers and cytokines as SCCAg, CYFRA 21.1, IL-6, VEGF and sTNF receptors in patients with squamous cell cervical cancer, particularly with early stage of the disease vol.37, pp.1, 2016, https://doi.org/10.1007/s13277-015-3914-0
- Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing vol.13, pp.1, 2018, https://doi.org/10.1186/s13027-018-0178-5